Page 1 of Clinical Trials for Drug Rivastigmine capsule, 17 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
Long-term Safety of Rivastigmine Capsule and Patch in Patients With Mild to Moderately-severe Dementia Associated With Parkinson's Disease (PDD)
Last Updated: October 19, 2011
Condition(s): Parkinson's Disease Dementia
2
Completed
Efficacy and Safety of Rivastigmine Capsules in Patients With Probable Vascular Dementia
Last Updated: November 16, 2011
Condition(s): Vascular Dementia
3
Completed
Convenience, Tolerability, and Safety of Change in the Administration of Rivastigmine From Capsules to a Transdermal Patch in Patients With Mild to Moderate Alzheimer's Disease
Last Updated: February 24, 2011
Condition(s): Alzheimer's Disease
4
Completed
Rivastigmine Capsules in Patients With Probable Vascular Dementia
Last Updated: November 16, 2011
Condition(s): Vascular Dementia
5
Completed
Safety and Tolerability of Rivastigmine With Add-on Memantine in Patients With Probable Alzheimer's Disease
Last Updated: December 17, 2007
Condition(s): Alzheimer's Disease
6
Completed
Bioequivalence Study of Rivastigmine Capsules 1.5 mg of Dr.Reddy's Under Fed Conditions
Last Updated: June 16, 2010
Condition(s): Healthy
7
Not yet recruiting
Tolerability of Rivastigmine Before and After Switching From Oral Formulation to Transdermal Patch in Alzheimer's Dementia
Last Updated: April 24, 2012
Condition(s): Alzheimer's Dementia
8
Completed
Clinical Effectiveness of 10 cm^2 Rivastigmine Patch in Patients With Alzheimer's Disease
Last Updated: April 10, 2012
Condition(s): Alzheimer's Disease
9
Recruiting
A 24-Week Efficacy, Safety and Tolerability of Rivastigmine Patch Study in Patients With Probable Alzheimer's Disease
Last Updated: April 24, 2012
Condition(s): Alzheimer's Disease
10
Completed
Bioequivalence Study of Rivastigmine 1.5 mg Capsules Under Fasting Conditions
Last Updated: January 12, 2012
Condition(s): Healthy
11
Not yet recruiting
A Double-Blind, Placebo-Controlled Crossover Study of Repeat Rivastigmine (Exelon®) Administration in Young Healthy Male Volunteers
Last Updated: February 15, 2008
Condition(s): Rivastigmine Toxicity
12
Completed
Safety, Tolerability, and Pharmacokinetic Study of EVP-6124 in Patients With Alzheimer's Disease
Last Updated: April 18, 2012
Condition(s): Alzheimer's Disease; Central Nervous System Diseases
13
Completed
The Effects of the Rivastigmine Patch on Parkinson's Disease With Memory and/or Thinking Problems
Last Updated: February 14, 2011
Condition(s): Parkinsons Disease With Dementia; Parkinsons Disease With Mild to Moderate Memory and/or Thinking Problems
14
Completed
Rivastigmine as a Treatment for Methamphetamine Dependence
Last Updated: February 20, 2012
Condition(s): Methamphetamine Dependence; Substance Abuse; Methamphetamine Abuse
15
Recruiting
Rivastigmine and Huperzine A as Treatments for Cocaine Dependence
Last Updated: February 20, 2012
Condition(s): Cocaine Dependence; Cocaine Addiction; Cocaine Abuse; Substance Abuse
16
Completed
RIVastigmine In Vascular cognitivE Impairment
Last Updated: April 29, 2008
Condition(s): Cognitive Impairment
17
Completed
A Study to Determine the Clinical Safety/Tolerability and Exploratory Efficacy of EHT 0202 as Adjunctive Therapy to Acetylcholinesterase Inhibitor in Mild to Moderate Alzheimer's Disease
Last Updated: September 18, 2009
Condition(s): Alzheimer's Disease

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Drug+Rivastigmine+capsule

Page 1 of Clinical Trials for Drug Rivastigmine capsule, 17 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About